Article
Advancing Clinical Trial Equity
Increasing diversity and equity in clinical trials will require buy-in and commitment from all stakeholders in the research enterprise. In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
In spring 2021, ACCC and Harborside hosted a Virtual Summit to Define on the Role Oncology Advanced Practitioners in Equitable Cancer Care Delivery. Each summit session focused one specific domain of care delivery—Care Coordination and Communication; Clinical Trials; and Acknowledging and Mitigating Implicit Bias.
Related Topics
You May Also Like
Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
Transforming oncology: Five frontiers driving progress in cancer care
Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Article